Prostate Cancer - Results from #19280

Particle radiotherapy for prostate cancer - Abstract December 5, 2014

#SUO14 - Session Highlights: Declining rate of prostate biopsy in the Veterans Health Administration in the past decade: An alternate approach to limiting overdiagnosis and overtreatment of prostate cancer? December 5, 2014

Best evidence regarding the superiority or inferiority of robot-assisted radical prostatectomy - Abstract December 5, 2014

Clinical utility of 18 F-fluorocholine PET-CT in biochemical relapse of prostate cancer after radical treatment: Results of a multicentre study - Abstract December 5, 2014

Establishment of a new prostate cancer multidisciplinary clinic: Format and initial experience - Abstract December 5, 2014

Is there any prognostic impact of intraductal carcinoma of prostate in initial diagnosed aggressively metastatic prostate cancer? - Abstract December 5, 2014

Psychosocial adjustments in patients with prostate cancer from pre-diagnosis to 6 months post-treatment - Abstract December 5, 2014

#SUO14 - Session Highlights: Targeting hormone-DNA repair crosstalk in prostate cancer: Implications for disease progression and therapeutic intervention December 5, 2014

#SUO14 - Session Highlights: Radical prostatectomy for oligometastatic disease December 5, 2014

The association between nerve sparing and a positive surgical margin during radical prostatectomy - Abstract December 5, 2014

#SUO14 - Session Highlights: Role of post-op RT for pN+ after prostatectomy December 4, 2014

Empiric antibiotics therapy for mildly elevated prostate specific antigen: Helpful to avoid unnecessary biopsies? - Abstract December 4, 2014

#SUO14 - Session Highlights: Role of surgery for nodal oligometastatic disease in men with biochemical failure December 4, 2014

#SUO14 - Session Highlights: Checkpoint targeted immunotherapy December 4, 2014

#SUO14 - Session Highlights: Imaging for biochemical recurrence December 4, 2014

#SUO14 - Session Highlights: Should MR be the standard of care before biopsy? December 4, 2014

#SUO14 - Session Highlights: Histology vs. genomics: Does Gleason 3 have the hallmarks of cancer? December 4, 2014

#SUO14 - Session Highlights: Is a 12-core biopsy of any value in patients with a previous negative prostate biopsy and visible lesion on magnetic resonance imaging? December 4, 2014

Pharmacotherapeutic management of metastatic, castration-resistant prostate cancer in the elderly: Focus on non-chemotherapy agents - Abstract December 4, 2014

Is prostate cancer changing?: Evolving patterns of metastatic castration-resistant prostate cancer - Abstract December 3, 2014

Page 965 of 1438